Lucas Mendes Barbosa

Lucas Mendes Barbosa

Auto-generated profile, based on publicly available information

Lucas Mendes Barbosa

Federal University of Minas Gerais, Belo Horizonte, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2024 in International Journal of Retina and Vitreous
Verified
Journal Article
Open access
PDF file
TRTiago N. O. Rassi
Tiago N. O. Rassi
LBLucas M. Barbosa
Lucas M. Barbosa
SPSacha Pereira
Sacha Pereira
ENEduardo A. Novais
Eduardo A. Novais
FPFernando Penha
Fernando Penha
MMMauricio Maia
Mauricio Maia
Background: Age-related macular degeneration (AMD) is a leading cause of vision loss. Photobiomodulation (PBM) offers a controversial approach for managing dry AMD, aiming to halt or reverse progression through mitochondrial activity modulation. However, the efficacy and clinical relevance of PBM as a potential approach for managing dry AMD remain debated. Methods: We systematically searched PubMed, Embase, and Cochrane databases for randomized controlled trials (RCTs) comparing PBM versus a sham in patients with dry AMD. We performed trial sequential analysis (TSA) and minimal clinically important difference (MCID) calculations to assess statistical and clinical significance applying a random-effects model with 95% confidence intervals (CI). Results: We included three RCTs comprising 247 eyes. The pooled analysis showed that PBM significant improved BCVA (MD 1.76 letters; 95% CI: 0.04 to 3.48) and drusen volume (MD -0.12 mm³; 95% CI: -0.22 to -0.02) as compared with a sham control. However, the TSA indicated that the current sample sizes were insufficient for reliable conclusions. No significant differences were observed in GA area. The MCID analysis suggested that the statistically significant results did not translate into clinically significant benefits. In the quality assessment, all studies were deemed to have a high risk of bias. Conclusion: This meta-analysis points limitations in the current evidence base for PBM in dry AMD treatment, with issues around small sample sizes. Statistically significant improvements do not translate into clinical benefits. The research underscores need for larger RCTs to validate PBM’s therapeutic potential for dry AMD.

8 January 2026 in Heart Rhythm
Verified
Journal Article
Closed access
LBLucas M. Barbosa
Lucas M. Barbosa
VOVinícius Martins Rodrigues Oliveira
Vinícius Martins Rodrigues Oliveira
ARAndré Rivera
André Rivera
BABeatriz Araújo
Beatriz Araújo
DCDavid Curi Barbosa Izoton Cabral
David Curi Barbosa Izoton Cabral
DBDeepak L. Bhatt
Deepak L. Bhatt

1 September 2025 in EP Europace
Verified
Journal Article
Open access
BABeatriz Araújo
Beatriz Araújo
ARAndré Rivera
André Rivera
VTVanessa de Oliveira Tapioca
Vanessa de Oliveira Tapioca
LBLucas M Barbosa
Lucas M Barbosa
LCLucas Caetano
Lucas Caetano
ANAndrea Natale
Andrea Natale
Aims: Catheter ablation is the standard treatment for symptomatic atrial fibrillation (AF) and can be performed under general anaesthesia (GA) or varying levels of sedation to optimize patient comfort and lesion formation. However, the effect of different anaesthesia strategies on AF recurrence rates remains uncertain. Methods and results: We systematically searched PubMed, Embase, Cochrane, and ClinicalTrials.gov for randomized controlled trials (RCTs) and observational studies comparing outcomes of catheter ablation under GA vs. sedation (including deep, moderate, and conscious sedation). We pooled risk ratios (RR) with 95% confidence intervals (CI) with a random effects model. R version 4.4.1 was used for statistical analyses. Our systematic review and meta-analysis included 6 RCTs and 17 observational studies, corresponding to 12 302 patients assigned to either sedation (n = 8952) or GA (n = 3350). There was no difference in recurrence of atrial tachyarrhythmias (ATAs) between groups (RR 1.15; 95% CI 0.97–1.36; P = 0.10; 95% prediction interval 0.66–2.01). There was no significant subgroup interaction in the recurrence of AF according to sedation type (conscious vs. mild vs. moderate sedation vs. deep sedation) (P = 0.20) or AF type (persistent AF vs. non-persistent) (P = 0.20). Conclusion: In patients undergoing catheter ablation for AF, there was no significant difference in recurrence of ATA between GA and sedation.

16 November 2024 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
LRLivia Romariz
Livia Romariz
BABeatriz Araújo
Beatriz Araújo
LBLucas M. Barbosa
Lucas M. Barbosa
RJRiddhi Jain
Riddhi Jain
CJCarolina Castro Porto Silva JANOVSKY
Carolina Castro Porto Silva JANOVSKY

30 November 2024 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
IQIvo Queiroz
Ivo Queiroz
TPTúlio Pimentel
Túlio Pimentel
MRMariano Gallo Ruelas
Mariano Gallo Ruelas
ATArthur Henrique Tavares
Arthur Henrique Tavares
LBLucas M. Barbosa
Lucas M. Barbosa
FPFernando Nunes Pimentel
Fernando Nunes Pimentel

9 September 2025 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
LBLucas M. Barbosa
Lucas M. Barbosa
VOVinícius Martins Rodrigues Oliveira
Vinícius Martins Rodrigues Oliveira
IQIvo Queiroz
Ivo Queiroz
NPNatanael de Paula Portilho
Natanael de Paula Portilho
WFWilliam Jakymiu Furtado
William Jakymiu Furtado
MNMaria Do Carmo P. Nunes
Maria Do Carmo P. Nunes